Biotricity financials at a glance

+ Portfolio

The revenue of Biotricity is reported as 0.00964 billion Dollars in the fiscal year 2024. The earnings were -1.96 Dollars per share in 2024, which was 50.88 higher than 2022. And about 0 billion Dollars are reported as free cash flow in the financials of Biotricity 2024. No dividends were paid to the shareholders of the Biotricity stock NasdaqCM:BTCY in the financial year 2024.

$9.64M

Revenue

$-1.96

Earnings Per Share

56.46%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

9.64

Earnings Per Share

-1.96

Gross Margin %

56.46

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022
Rev.	Revenue	N/A	$9.64M	$7.65M
GM %	Gross Margin %	61.66%	56.46%	59.74%
OM	Operating Margin	-,106.12%	-,159.87%	-,224.90%
EPS	Earnings Per Share	$-1.95	$-1.96	$-3.99
Div.	Dividends	N/A	$0.00	$0.00
PR %	Payout Ratio %	0	0	0
Sha.	Shares	N/AM	9.97M	9.85M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.09	$-1.67	$-0.36

Biotricity financials at a glance

Financials

Discover